Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 71.00
0.00 (0.00%)
Aug 28, 2026, 1:30 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 13.37 billion as of August 28, 2026. Its market cap has decreased by -5.92% in one year.
Market Cap
13.37B
Enterprise Value
14.65B
Revenue
9.20B
Ranking
n/a
PE Ratio
14.57
Stock Price
71.00
ChartMarket Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 13.37B, an increase of 435.20%. That is a compound annual growth rate of 7.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 13.37B | -4.47% |
| Dec 31, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 646.51B |
| Caliway Biopharmaceuticals | 160.21B |
| Pell Bio-Med Technology | 97.62B |
| Lin BioScience | 77.77B |
| YungShin Global Holding | 14.92B |
| Grape King Bio | 13.42B |
| Lumosa Therapeutics | 13.30B |
| TaiDoc Technology | 13.08B |